-
Cara Therapeutics' 15% Surge, Explained
Tuesday, March 28, 2017 - 8:58am | 542Shares of Cara Therapeutics Inc (NASDAQ: CARA), a small-cap clinical-stage bio-pharmaceutical company that develops therapies to alleviate pain, gained more than 15 percent early Tuesday morning after the company announced encouraging results from Part A of a Phase 2/3 trial. Cara has been...